Following Schamberg's introduction of gold sodium thiosulphate in the treatment for lupus erythematosus, several reports appeared on the use of this and similar compounds. For three years these drugs have been widely employed, and it now seems that an attempt to appraise their value in the light of a longer experience would be worth while.
The use of gold compounds in the treatment of patients with lupus erythematosus dates from 1913, when Reute1 first reported the use of gold potassium cyanide in a case lupus erythematosus. From that time until almost ten years later, little was written on this type of therapy, although in 1917 Adolf Feldt2 had prepared a new gold compound, 4-amino-2-aurothiophenol carbonic acid, and had been using it with considerable success in the treatment for various types of systemic tuberculosis.
In 1921, Kohrs3 reported a case of lupus erythematosus with cure by this drug,
RUTLEDGE WU. LUPUS ERYTHEMATOSUS: TREATMENT WITH GOLD PREPARATIONS. Arch Derm Syphilol. 1931;23(5):874–883. doi:10.1001/archderm.1931.03880230050006
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: